Cancer drugs among nearly 400 medicines at risk of shortage in UK - Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable ...

Department health, not Treasury, will foot the bill – with costs forecast to reach £9bn ...

This combination, a drastic transformation that feels organic rather than politically imposed, makes the rise of vice a useful point of entry into the debate about liberalism’s crisis. It’s a vivid ...

The dour mood around tech has turned a spotlight on chipmaker AMD's after-hours earnings report, which could provide the best ...

Ozempic® was estimated to have generated approximately C$2.9 billion in Canadian sales in 2025 (Source: IQVIA Canada). Industry estimates suggest the broader GLP-1 receptor agonist opportunity in ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

Health costs are a top concern for Americans. Two-thirds of the public say they are somewhat or very worried about affording health care.

For patients staring at a life-or-death choice, duty-free does not mean affordable—and hope remains priced like a luxury.

3 ½ things healthcare could do differently ...

Back-to-back trade agreements with the EU and US - one hailed as the "mother of all deals" and the other to slash tariffs on Indian goods to 18% - are widely expected to boost the economy, adding a ...

United States President Donald Trump announced a trade deal with India, reducing US tariffs on Indian goods from 50% to 18%, ...

Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...